Patents by Inventor Dario Mosca

Dario Mosca has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS DERIVED FROM STEROLS FOR THE TREATMENT OF A DISEASE ASSOCIATED WITH A MITOCHONDRIAL DEFICIT
    Publication number: 20260183311
    Abstract: A sterol-based compound of formula (I) for its use in preventing, ameliorating and/or treating a mitochondrial deficiency-related pathology chosen from the group consisting of autism, spinal cord injury, multiple sclerosis, epilepsy, migraine, alcohol-related mental pathologies, ataxia, neuropathies, smoking-related cerebral and pulmonary disorders, MERRF syndrome and NARP syndrome. A pharmaceutical composition comprising at least one compound of formula (I).
    Type: Application
    Filed: June 14, 2023
    Publication date: July 2, 2026
    Applicant: DENDROGENIX
    Inventors: Stéphane SILVENTE, Nicolas CARON, Arnaud RIVES, Quentin MARLIER, Hélène MICHAUX, Dario MOSCA, Maxime GILSOUL
  • PRODRUG OF 5a-HYDROXY-6ß-[2-(1H-IMIDAZOL-4-YL)ETHYLAMINO]CHOLESTAN-3ß-OL AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME FOR USE IN THE TREATMENT OF CANCER
    Publication number: 20240002429
    Abstract: The invention relates to a novel compound of general formula (I): and/or a pharmaceutically acceptable salt of a compound of this kind, a pharmaceutical composition comprising at least said compound, for use thereof as a drug for causing regression of a mammalian cancerous tumor.
    Type: Application
    Filed: December 3, 2021
    Publication date: January 4, 2024
    Applicant: DENDROGENIX
    Inventors: Stéphane SILVENTE, Quentin MARLIER, Arnaud RIVES, Nicolas CARON, Dario MOSCA, Hélène MICHAUX
  • 5ALPHA-HYDROXY-6BETA-[2-(1-H-IMIDAZOL-4-YL)-ETHYLAMINO]-CHOLESTAN-3BETA-OL ANALOGUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME FOR USE IN THE TREATMENT OF CANCER
    Publication number: 20230391817
    Abstract: The invention relates to a novel compound of general formula (I): and/or a pharmaceutically acceptable salt of such a compound, to a pharmaceutical composition comprising at least said compound, for its use as a medicament for shrinking a mammalian cancerous tumor.
    Type: Application
    Filed: October 28, 2021
    Publication date: December 7, 2023
    Applicant: DENDROGENIX
    Inventors: Stéphane SILVENTE, Quentin MARLIER, Arnaud RIVES, Nicolas CARON, Dario MOSCA, Hélène MICHAUX
  • CO-POLYMERS
    Publication number: 20190315988
    Abstract: Co-polymers formed from at least one monomer of formula (A) and at least one monomer of formula (B): (A) (B) wherein R1, R2, R3 and L are as defined herein; may be dispersed or dissolved in an organic solvent which optionally contains carbon nanostructures. A substrate coated or printed with the dispersion or solution may be used in an electrochromic device.
    Type: Application
    Filed: October 20, 2017
    Publication date: October 17, 2019
    Inventors: Davide Bonifazi, Dario Mosca, César Laia, Jorge Parola, Fernando Pina, Carlos Pinherio